InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by BRADY ANN, Chairman & CEO. Officer active across 1 companies, notably Theravance Biopharma, Inc.. Cumulatively, 7 filings have been published. The latest transaction was disclosed on 18 February 2022 — Retenue fiscale. Regulator: SEC (Form 4). The full history is openly available.
Declarations7 total
€70,7578,369 shares@ €8.45470.0085% mcap24.7% of flow
Ordinary Shares
SEC:0001415889-22-001693:0·
€23,3043,169 shares@ €7.35370.0028% mcap21.7% of flow
Ordinary Shares
SEC:0001415889-21-005472·
€23,3043,169 shares@ €7.35370.0028% mcap8.2% of flow
Ordinary Shares
SEC:0001415889-21-005472:0·
€38,1313,169 shares@ €12.03260.0046% mcap35.4% of flow
Ordinary Shares
SEC:0001179110-21-008390·
€38,1313,169 shares@ €12.03260.0046% mcap13.3% of flow
Ordinary Shares
SEC:0001179110-21-008390:0·
€46,1403,169 shares@ €14.55990.0055% mcap42.9% of flow
Ordinary Shares
SEC:0001179110-21-005838·
€46,1403,169 shares@ €14.55990.0055% mcap16.1% of flow
Ordinary Shares
SEC:0001179110-21-005838:0·
7 of 7 declarations
About BRADY ANN
Ann Brady is the Chairman & CEO of Theravance Biopharma, Inc. She leads the company's operations and is responsible for the overall strategy. Her role includes overseeing research and development activities and managing stakeholder relationships. She plays a key role in the growth and innovation of the organization.
